June 2016: European Meeting Re: Psychiatry in Crisis?

In his article in the BMJ, “Psychiatry in crisis? Dr. Richard Smith, former editor of the BMJ (British Medical Journal) summarizes the message delivered by several speakers at a meeting also convened in June 2016. This meeting took place in Leiden, the . . . Continue reading →

Testimony Against SF 2841-Minnesota – Preschool Socioemotional Screening–Karen Effrem, MD.

I am here in vigorous opposition to SF 2841 that would implement mental health screening for three-year-old children entering public school. Continue reading →

TeenScreen Operations Have Shut Down

teenscreen-not-lab-rat.jpg

   The following announcement was posted on TeenScreen’s website (November 15, 2012):  "Important Announcement for Schools & Communities:  We are sorry to inform you that the TeenScreen National Center will be winding down its program at the end of this year. Accordingly, . . . Continue reading →

Confidential Expert Witness Report Documents Psychiatrists’ Corrupt Practices

"From the start, the [Tri-University Schizophrenia Practice Guidelines] project subverted scientific integrity, appearing to be a purely scientific venture when it was at its core, a marketing venture for Risperdal."

Continue reading →

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

"When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.” Continue reading →

US Gov Medical Experiment Radically Departs from medical “Best Practices”

The US government is initiating several radical medical experiments that will ensure widespread, increased use of mostly toxic drugs whose adverse effects trigger chronic, debilitating illnesses.

Continue reading →

AHRP Letter to Harvard Re: Dr. Biederman’s Research

ahrp_logo.jpg

AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies. Continue reading →

Rolling Stone – Marketing a Phony “Miracle” Drug

“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
Continue reading →

Letter of Complaint Re: FDA Double Agent

vera_signature.png

A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.  Continue reading →